Clinical Viewpoint: Heartburn: A Drug and Natural Medicine Review

Kiska, Thomas A.
October 2013
Nutritional Perspectives: Journal of the Council on Nutrition;Oct2013, Vol. 36 Issue 4, p23
Academic Journal
HEARTBURN is defined as a "burning sensation in the substernal area due to reflux of acid contents of the stomach into the lower esophagus" by Taber's Medical Dictionary.1 The purpose of this document is to define heartburn, review the physiology of heartburn and the gastric system, review both the drug and natural medicine application for the treatment of heartburn and discuss the health benefits and adverse side-effects of the common treatments.


Related Articles

  • Soothe the fire in your belly.  // Consumer Reports on Health;Jul2012, Vol. 24 Issue 7, p1 

    No abstract available.

  • What medications are safe and effective for heartburn during pregnancy? Koenig, Clint J.; Marquardt, Donald N. // Journal of Family Practice;Apr2001, Vol. 50 Issue 4, p304 

    The article answers a query on which medications are safe and effective for heartburn during pregnancy. The best-studied agent for treatment of heartburn in pregnancy is ranitidine. Metoclopromide, proton pump inhibitors, and sucralfate are probably safe in pregnancy, but there are no data about...

  • Heartburn meds: Interactions, contraindications important. Guthrie, Ellen Whipple // Pharmacy Today;Oct2006, Vol. 12 Issue 10, p30 

    The article focuses on heartburn disease and different over-the-counter (OTC) medications for American patients. It has been estimated that 19 million patients take OTC medications, which include antacids, histamine-2 antagonists and proton pump inhibitors (PPI). Antacids neutralize stomach acid...

  • Brand loyalty in heartburn relief keeps OTC switch sales on top.  // Drug Store News;10/24/2005, Vol. 27 Issue 14, p19 

    Reports on antacid tablet sales in the U.S. Brand loyalty of antacid tablet buyers; Sales of Zantac 150, Prilosec and Maximum Strength Pepcid AC.

  • Heartburn, gastro-oesophageal reflux disease and nonerosive reflux disease. Smith, Haley // South African Pharmaceutical Journal;2013, Vol. 80 Issue 1, p16 

    Recognising nonerosive reflux disease (NERD) as a distinct presentation of gastro-oesophageal reflux disease (GORD) has been one of the most important developments in the field of GORD. Therapeutic modalities still focus on acid suppression for the management of heartburn, GORD and NERD....

  • Bisodol Heartburn Relief.  // Royal Society of Medicine: Medicines;2002, p116 

    The article presents information on Bisodol Heartburn Relief, a proprietary, non-prescription compound preparation of the antacid sodium bicarbonate and magaldrate, and the alginic acid. This drug can be used to relieve indigestion and heartburn and is available as tablets. However, this drug is...

  • Should the concomitant use of erlotinib and acid-reducing agents be avoided? The drug interaction between erlotinib and acid-reducing agents. Duong, Silvia; Leung, Mova // Journal of Oncology Pharmacy Practice;Dec2011, Vol. 17 Issue 4, p448 

    Context. Erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, exhibits a drug interaction with proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs). The manufacturer recommends avoidance of the combination however, the extent of the drug interaction is...

  • Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. Katz, Philip O; Gerson, Lauren B; Vela, Marcelo F // American Journal of Gastroenterology;Mar2013, Vol. 108 Issue 3, p308 

    The article disuses guidelines related to treatment and diagnosis of gastroesophageal reflux disease (GERD). Prevalence of GERD on the basis of symptoms regurgitation and heartburn is discussed. Treatment of GERD includes use of histamine-receptor antagonists, antacids and proton pump inhibitor...

  • Proton Pump Inhibitors.  // Current Medical Literature: Gastroenterology;2008, Vol. 27 Issue 4, p120 

    The article presents abstracts of research on proton pump inhibitors (PPI) including the "Addition of H2 Receptor Antagonist to PPI in Improving Acid Control and Decreases Nocturnal Acid Breakthrough," and "Predictable Prolonged Suppression of Gastric Acidity With a Novel Proton Pump Inhibitor,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics